Giant cell arteritis

Area of Science:

• Rheumatology
• Immunology
• Vascular Medicine

Background:

• Giant cell arteritis (GCA) is the most common systemic vasculitis in adults over 50.
• It primarily affects large and medium arteries, with classic symptoms including headache, jaw claudication, polymyalgia rheumatica (PMR), and visual disturbances.
• A significant proportion (40%) of patients exhibit occult manifestations, complicating early diagnosis.

Purpose of the Study:

• To summarize the key aspects of Giant Cell Arteritis, including its clinical presentation, pathogenesis, diagnostic methods, and treatment outcomes.
• To highlight the importance of early diagnosis and treatment in preventing severe complications such as blindness.
• To discuss the current understanding of GCA pathogenesis and its association with other vascular conditions like thoracic aortic aneurysms.

Main Methods:

• Review of existing literature on Giant Cell Arteritis.
• Analysis of clinical manifestations, diagnostic criteria, and treatment strategies.
• Inclusion of findings from recent clinical trials regarding treatment efficacy.

Main Results:

• GCA presents with diverse symptoms, with many cases having non-classic, occult manifestations.
• Early diagnosis and treatment with prednisone are vital to avert blindness, the most feared complication.
• The pathogenesis involves T-cell responses and cytokine variations, and GCA increases the risk of thoracic aortic aneurysms.
• Advanced imaging techniques provide insights but temporal artery biopsy remains the gold standard for diagnosis.

Conclusions:

• Giant cell arteritis requires prompt diagnosis and treatment, primarily with prednisone, to prevent vision loss.
• The disease's pathogenesis is complex, involving immune responses and potentially leading to serious vascular complications.
• Conflicting results from recent trials necessitate further research into optimal treatment regimens, such as the combination of methotrexate and prednisone.